1. What Is the Size Exclusion Resin Market?
The Size Exclusion Resin Market encompasses porous polymer and silica gel chromatography bead media used in size exclusion chromatography columns to separate molecules by hydrodynamic volume. This enables molecular weight distribution analysis of polymers for quality control, protein molecular weight characterisation for biopharmaceutical development, and purification of oligonucleotide and peptide therapeutic molecules by size. The market includes agarose gel filtration resin for protein and biomolecule molecular weight characterisation in life science research and cross-linked dextran Sephadex resin for desalting and small molecule removal in biopharmaceutical process steps. It also includes polystyrene-divinylbenzene macroporous SEC resin for polymer molecular weight distribution analysis in industrial quality control. It also includes silica SEC column packing for high-performance GPC of synthetic polymers and multi-modal SEC resin for combined size and charge separation of biopharmaceutical aggregates. These resins are consumed by polymer manufacturer quality control laboratories using GPC for molecular weight distribution measurement of polyethylene, polypropylene, and engineering polymer production batches. Biopharmaceutical analytical development laboratories use them to characterise protein therapeutic size and aggregation. They are also consumed by biopharmaceutical process chromatography operations purifying polysaccharide and oligonucleotide therapeutics and academic polymer chemistry research institutions. Market scope covers porous SEC chromatography resin media for size-based molecular separation and analysis in both analytical and preparative scale chromatography applications. It excludes HPLC reversed-phase and ion exchange resins without size exclusion mechanism, size exclusion chromatography column hardware and instrument systems without resin media content, and ultrafiltration membranes for size-based separation without resin-based mechanism.
2. Size Exclusion Resin Market Size & Forecast
3. Emerging Technologies
- Multimodal SEC resin combining size exclusion and charge interaction for mAb aggregate removal is advancing mixed-mode agarose resin functionalised with ionic ligands providing simultaneous size exclusion and weak ionic charge interaction. Growing biopharmaceutical process chromatography interest in improved aggregate clearance at polishing chromatography stages is motivating multimodal SEC-ionic mixed-mode resin development.
- Sub-micron porous silica SEC particle development for ultra-high-resolution polymer GPC is advancing 1_5 to 3 micron sub-2-micron porous silica SEC particle development compatible with ultra-high-performance liquid chromatography UPLC instrument pressure ratings. Growing polymer analytical chemist interest in UPLC-compatible SEC resin for improved GPC resolution and faster analysis throughput is motivating sub-2-micron silica SEC particle development.
- On-column SEC-MALS coupling optimisation for absolute molecular weight determination is advancing SEC resin column void volume and flow distribution optimisation enabling direct coupling with multi-angle light scattering MALS detector for absolute molecular weight determination. Growing polymer and biopharmaceutical analyst interest in standard-free absolute molecular weight from SEC-MALS is motivating SEC column and resin void volume optimisation for MALS compatibility.
- Continuous SEC process chromatography for biopharmaceutical productivity is advancing carousel and simulated moving bed continuous SEC operation for oligonucleotide and mRNA therapeutic purification providing higher resin productivity than batch column operation. Growing CDMO and biopharmaceutical process chemist interest in continuous SEC for reduced resin volume and buffer consumption per gram of therapeutic product purified is motivating continuous SEC process development.
Similar technologies are also transforming adjacent markets. Learn more in our Chromatography Resin Market.
4. Key Market Opportunity
A major opportunity in the Size Exclusion Resin Market is the expansion of preparative SEC resin demand from the growing RNA therapeutic and oligonucleotide drug manufacturing pipeline as mRNA vaccine scale-up, siRNA therapeutic clinical advancement, and antisense oligonucleotide commercial manufacturing generate preparative SEC. A significant proportion of RNA and oligonucleotide therapeutic clinical programmes currently at Phase 2 and Phase 3 will advance to commercial manufacturing approval requiring preparative SEC resin at multi-kilogramme batch scale substantially above Phase 1 and 2 research resin consumption. Preparative SEC resin providing oligonucleotide and mRNA product polishing at commercial manufacturing scale removes truncated sequences and process aggregates meeting regulatory specification without adding impurities at GMP-grade resin quality. SEC resin producers that develop GMP-certified preparative agarose SEC resin with validated oligonucleotide and mRNA aggregate clearance performance, build CDMO supply qualification, and scale preparative resin manufacturing capacity are positioned to capture growing RNA therapeutic SEC resin demand.
5. Top Companies in the Size Exclusion Resin Market
The following organisations hold leading positions in the Size Exclusion Resin Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Cytiva (Sephadex/Superdex)
- Tosoh Bioscience (TSKgel)
- Waters Corporation (Styragel)
- Merck KGaA (Supelco)
- Bio-Rad Laboratories
- Phenomenex
- Sepax Technologies
- Purolite (Ecolab)
- Agilent Technologies
- Thermo Fisher Scientific
6. Market Segmentation
The Size Exclusion Resin Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Resin Base | Agarose Gel Dextran Cross-Linked PS-DVB Macroporous Silica Porous Methacrylate |
| By Scale | Analytical SEC Preparative SEC Process Scale |
| By Application | Polymer MW Analysis Protein Characterisation Biopharm Purification Desalting Oligonucleotide |
| By End User | Polymer QC Lab Biopharma R&D Process Biopharma Academic Research Contract Lab |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Size Exclusion Resin Market trajectory over the forecast period:
Cytiva Sephadex and Superdex Dominate Biopharmaceutical Protein SEC Resin.Biopharmaceutical analytical development and process chromatography operations characterising and purifying monoclonal antibody, fusion protein, and vaccine antigen specify Cytiva Sephadex G-200. Superdex 200 agarose gel SEC resin providing molecular weight fractionation from 3,000 to 600,000 daltons in aqueous buffered conditions compatible with protein tertiary structure maintenance during analysis, with Cytiva's Sephadex. Superdex franchise sustained by decades of biopharmaceutical characterisation method validation. Cytiva continued Sephadex and Superdex SEC resin delivery to biopharmaceutical analytical and process chromatography customers in 2024, with consistent demand from mAb analytical development programmes and growing protein biopharmaceutical pipeline characterisation applications.
Waters Styragel and Tosoh TSKgel Dominate Polymer GPC SEC Resin for Industrial Quality Control.Polymer producer quality control laboratories using GPC for molecular weight distribution measurement of polyethylene, polypropylene, polystyrene, polyurethane, and engineering resin production batches specify Waters Styragel and Tosoh TSKgel polystyrene-divinylbenzene. Silica macroporous SEC column packing providing molecular weight fractionation from 1,000 to several million daltons in THF, DMF, and aqueous solvents compatible with polymer GPC analysis conditions. Waters and Tosoh Bioscience continued Styragel and TSKgel SEC column and resin delivery to polymer QC laboratory and industrial research customers in 2024. Consistent demand from polymer producer GPC quality assurance analysis at batch release and product development stages.
Oligonucleotide Purification by Preparative SEC Is Growing with RNA Therapeutic Pipeline Expansion.Contract development and manufacturing organisations purifying synthetic RNA siRNA, antisense oligonucleotide, and mRNA therapeutic candidates from process-related impurities use preparative scale SEC resin fractionation as a polishing step removing truncated oligonucleotide sequences. Process-derived aggregates below the size fractionation range of the target therapeutic oligonucleotide at kilogramme-scale preparative column format. Cytiva and Purolite continued preparative SEC resin delivery to oligonucleotide CDMO and biopharmaceutical purification process customers in 2024, with growing RNA therapeutic clinical pipeline generating consistent preparative SEC resin demand from oligonucleotide manufacturing scale-up.
For related market intelligence, see the Size Exclusion Chromatography Market.
8. Segmental Analysis
By resin base, agarose gel SEC resin dominated the Size Exclusion Resin Market in 2025, driven by Cytiva Sephadex and Superdex agarose representing the standard biopharmaceutical protein SEC resin generating the highest combined analytical and. Cytiva Sephadex and Superdex agarose gel SEC resin consumption at biopharmaceutical analytical and preparative chromatography continues generating the highest SEC resin market revenue as agarose represents the standard SEC base for aqueous biomolecule fractionation at. Methacrylate-based SEC resins are the fastest-growing base material, driven by growing preparative and process SEC scale adoption of methacrylate SEC resin providing improved alkaline cleaning stability versus agarose for GMP bioprocessing applications. Growing biopharmaceutical process SEC preparative and GMP applications specifying methacrylate SEC resin for improved alkaline CIP stability versus agarose gel are generating methacrylate SEC base growth above agarose baseline rates.
By scale, analytical SEC resin dominated the Size Exclusion Resin Market in 2025, driven by the large biopharmaceutical and polymer analytical laboratory installed base generating analytical column resin as the highest volume application. Biopharmaceutical analytical development laboratory and polymer producer QC GPC column analytical SEC resin continue generating the highest market demand as analytical scale represents the largest SEC resin consumer by customer count and aggregate column volume. Process scale SEC resin is the fastest-growing, driven by growing oligonucleotide and mRNA therapeutic commercial manufacturing scale-up creating kilogramme-batch preparative and process SEC resin procurement above analytical volume growth rates. RNA therapeutic and oligonucleotide commercial manufacturing scale-up from clinical pipeline advancement is generating process scale SEC resin demand growth substantially above analytical scale as commercial manufacturing GMP batch resin consumption substantially exceeds analytical resin volumes.
9. Regional Analysis
Regional demand patterns across the Size Exclusion Resin Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Size Exclusion Resin Market in 2025, holding 42.0% of the global market. The region's dominance reflects Waters Corporation, Bio-Rad Laboratories, and Agilent Technologies as leading US-headquartered polymer GPC SEC column and instrument companies, the large North American biopharmaceutical analytical and process chromatography market as the world's largest SEC resin consumer for protein and oligonucleotide applications, and growing RNA therapeutic CDMO and manufacturer preparative SEC demand. Waters Styragel GPC column resin and the large North American biopharmaceutical analytical SEC resin consumption create the highest North American SEC resin market revenue as both the leading GPC SEC column supplier and the primary biopharmaceutical SEC resin demand geography. Growing North American RNA therapeutic and mRNA manufacturing preparative SEC demand and Cytiva and Bio-Rad North American protein SEC resin delivery create consistent North American sector leadership.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 9.50% during the forecast period. Growing Asian biopharmaceutical CDMO and mAb manufacturer analytical and preparative SEC resin demand, growing Chinese polymer producer GPC quality control SEC resin adoption, and growing Japanese and South Korean RNA therapeutic SEC resin manufacturing investment are driving above-average growth. Growing Chinese, Indian, and South Korean biopharmaceutical and CDMO analytical and process SEC resin demand from expanding Asia Pacific biopharmaceutical manufacturing creates consistent Asia Pacific SEC resin demand growth. Growing Asian polymer producer GPC SEC column adoption for quality control and growing RNA therapeutic CDMO SEC preparative resin demand in China and South Korea create consistent Asia Pacific size exclusion resin market demand growth.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Size Exclusion Resin Market was valued at USD 563.68 Mn in 2025 and is projected to reach USD 1,080.75 Mn by 2034, growing at a CAGR of 7.50% over the 2026–2034 forecast period.
The Size Exclusion Resin Market is projected to grow at a CAGR of 7.50% from 2026 to 2034.
North America accounted for the largest share of the Size Exclusion Resin Market in 2025, holding 42.0% of the global market.
The leading companies in the Size Exclusion Resin Market include Cytiva (Sephadex/Superdex), Tosoh Bioscience (TSKgel), Waters Corporation (Styragel), Merck KGaA (Supelco), Bio-Rad Laboratories, Phenomenex, Sepax Technologies, Purolite (Ecolab), Agilent Technologies, Thermo Fisher Scientific.
Cytiva sephadex and superdex dominate biopharmaceutical protein sec resin.
By resin base, agarose gel SEC resin dominated the Size Exclusion Resin Market in 2025, driven by Cytiva Sephadex and Superdex agarose representing the standard biopharmaceutical protein SEC resin generating the highest combined analytical and.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.